13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2026-01-13 Event 2026-01-09 SEC 0001699737-26-000003 →

Samsara BioCapital, L.P. ALUMIS INC. ALMS

Stake: 5.40% Shares: 6,345,219 CUSIP: 022307102 Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
5 transactions
3 buys · 2 sales · 0 awards/exercises
Issuer Cluster
8 13D/G filings on this issuer
7 other filings besides this one
Filer Track Record
7 filings by this filer
6 other filings in the data moat
Short Interest · settle 2026-08-31
DTC 7.07
5,645,753 shares short · -3.6% vs prior

Post-Filing Returns · since 2026-01-09 on ALMS

+1 day
+7.8%
+5 days
+24.4%
+30 days
+33.5%
+60 days
+43.7%
+90 days
+17.3%
+180 days
+52.0%

Anchor price 19.56 on closest trading day on/after 2026-01-09. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-08 AKKARAJU SRINIVAS director Sale 48,066 $10.55 $507K
2026-09-08 AKKARAJU SRINIVAS director Sale 48,065 $10.55 $507K
2026-09-08 AKKARAJU SRINIVAS director Buy 273,291 $10.63 $2.90M
2026-09-08 AKKARAJU SRINIVAS director Buy 273,290 $10.63 $2.90M
2026-09-04 AKKARAJU SRINIVAS director Buy 220,070 $11.17 $2.46M

Other 13D/G Filings on ALUMIS INC.

FiledFormFilerStakeShares
2026-08-17 SCHEDULE 13D Foresite Capital Fund VI LP 14.50% 2,203,800 view →
2026-08-06 SCHEDULE 13G FMR LLC view →
2026-07-27 SCHEDULE 13G BlackRock, Inc. view →
2026-07-02 SCHEDULE 13D/A AyurMaya Capital Management Company, LP 12.30% 15,139,707 view →
2026-04-03 SCHEDULE 13D/A Foresite Capital Fund VI LP 12.70% 4,247,670 view →
2026-01-12 SCHEDULE Foresite Capital Fund VI LP 14.10% 16,189,804 view →
2025-02-10 SCHEDULE AyurMaya Capital Management Company, LP 22.50% 10,645,966 view →

Other Filings by Samsara BioCapital, L.P.

FiledFormIssuerStakeShares
2026-05-28 SCHEDULE 13D/A RANI THERAPEUTICS HOLDINGS, INC. RANI 5,661,481 view →
2026-05-22 SCHEDULE 13D/A KALARIS THERAPEUTICS, INC. KLRS 54.20% 10,657,028 view →
2025-11-24 SCHEDULE Nkarta, Inc. NKTX 4.90% 3,507,666 view →
2025-09-03 SCHEDULE vTv Therapeutics Inc. VTVT 9.90% 343,223 view →
2025-03-17 SCHEDULE Mineralys Therapeutics, Inc. MLYS 9.10% 5,736,305 view →
2024-10-07 SC Scholar Rock Holding Corp SRRK view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →